Disseminated Langerhans cell histiocytosis in a 51-year-old man with cutaneous involvement and multiple endocrinopathies.
Open Access
- 24 September 2019
- journal article
- Published by Elsevier BV in JAAD Case Reports
- Vol. 5 (10), 835-837
- https://doi.org/10.1016/j.jdcr.2019.07.011
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Langerhans cell histiocytosis in childrenJournal of the American Academy of Dermatology, 2018
- Clinical Spectrum, Quality of Life, BRAF Mutation Status and Treatment of Skin Involvement in Adult Langerhans Cell HistiocytosisActa Dermato-Venereologica, 2017
- Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomesJCI Insight, 2017
- Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesBlood, 2016
- Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120Cancer Discovery, 2016
- Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutationBlood, 2014
- Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancyBritish Journal of Dermatology, 2012
- Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven casesActa Oncologica, 2012
- Langerhans cell histiocytosis in adultsReport from the International Registry of the Histiocyte SocietyEuropean Journal of Cancer, 2003
- Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis: Clinical, Endocrinological, and Radiological Features and Response to TreatmentJournal of Clinical Endocrinology & Metabolism, 2000